Practice parameter: Management of dementia (an evidence-based review)[RETIRED] Report of the Quality Standards Subcommittee of the American Academy of …

RS Doody, JC Stevens, C Beck, RM Dubinsky… - Neurology, 2001 - AAN Enterprises
Objective: To define and investigate key issues in the management of dementia and to make
literature-based treatment recommendations. Methods: The authors searched the literature …

Muscarinic acetylcholine receptor agonists as novel treatments for schizophrenia

SM Paul, SE Yohn, M Popiolek… - American Journal of …, 2022 - Am Psychiatric Assoc
Schizophrenia remains a challenging disease to treat effectively with current antipsychotic
medications due to their limited efficacy across the entire spectrum of core symptoms as well …

Cholinesterase inhibitors: a new class of psychotropic compounds

JL Cummings - American Journal of Psychiatry, 2000 - Am Psychiatric Assoc
OBJECTIVE: This article reviews evidence indicating that acetylcholinesterase inhibitors
have psychotropic properties. METHOD: The author reviewed the English-language …

[BOOK][B] Alzheimer disease.

RD Terry, RE Katzman, KL Bick - 1994 - psycnet.apa.org
The book begins with the history of Alzheimer's disease (AD), followed by clinical
considerations in diagnosis, psychiatry and psychology, clinical genetics, imaging …

Potential role of muscarinic agonists in Alzheimer's disease

EE Avery, LD Baker, S Asthana - Drugs & aging, 1997 - Springer
Alzheimer's disease (AD) is a common neurodegenerative disorder and a leading cause of
death among the elderly. Recent advances in our understanding of the neurobiology of AD …

[PDF][PDF] Cognitive effects of muscarinic M

RA McArthur, J Gray, R Schreiber - Current opinion in …, 2010 - researchgate.net
The limited effect of AChE inhibitors and NMDA receptor antagonists for the treatment of the
cognitive symptoms of Alzheimer's disease has prompted the search for new drugs that are …

Alzheimer's and non-Alzheimer's dementia: a critical review of pharmacological and nonpharmacological strategies

S Saddichha, V Pandey - American Journal of Alzheimer's …, 2008 - journals.sagepub.com
Objective. Dementia is an age-related progressive neurodegenerative disorder afflicting
about 5% of the world's population, and it is expected to grow dramatically in the future …

[BOOK][B] Diagnosis and management of Alzheimer's disease and other dementias

RC Green - 2004 - books.google.com
Differential diagnosis of Alzheimer's disease, dementia and delirium, diagnostic tests in
differential diagnosis, and indentifying underlying conditions that can cause dementia are …

Drugs for treatment of Alzheimer's disease

D Wilkinson - International journal of clinical practice, 2001 - Wiley Online Library
Alzheimer's disease is already an international problem of enormous significance, with an
estimated 500,000 sufferers in the UK alone. There are currently four licensed compounds …

An update on primary drug therapies for Alzheimer disease

DS Knopman, JC Morris - Archives of neurology, 1997 - jamanetwork.com
Propelled by remarkable advances in the understanding of the pathological characteristics
of Alzheimer disease (AD), the prospects for the treatment of the clinical disorder have …